Investor Alerts

You may opt into receiving press releases related to Aytu BioPharma, Inc. by submitting the form below. You will receive a follow-up email to confirm that you wish to be added to the mailing list.

* If you are a current subscriber and would like to update your subscription settings to receive alerts for Press Releases, SEC Filings, or End of Day Stock Quotes, please email us at cx@accessnewswire.com.